Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Hilmi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Nucleic Acids|October 21, 2011
VEGF spliced variants: possible role of anti-angiogenesis therapyCaroline Hilmi, Mélanie Guyot, Gilles Pagès
The Journal of Investigative Dermatology|December 15, 2007
IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivinCaroline Hilmi, Lionel Larribere, Sandy Giuliano, et al.
Oncotarget|December 22, 2016
Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategiesMélanie Guyot, Caroline Hilmi, Damien Ambrosetti, et al.
Current Biology : CB|May 16, 2003
Reconstituted skin from murine embryonic stem cellsChristelle Coraux, Caroline Hilmi, Matthieu Rouleau, et al.
Genes & Development|September 6, 2005
The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosisLionel Larribere, Caroline Hilmi, Mehdi Khaled, et al.
Endocrine-Related Cancer|October 1, 2008
ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2Sunil Pancholi, Anne E Lykkesfeldt, Caroline Hilmi, et al.
Pest Management Science|March 15, 2025
Aminoisothiazolamides, a new class of potent inhibitors of lysyl-tRNA synthetaseDavid Bernier, David M Barber, Guido Bojack, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Nucleic Acids|October 21, 2011
VEGF spliced variants: possible role of anti-angiogenesis therapyCaroline Hilmi, Mélanie Guyot, Gilles Pagès
The Journal of Investigative Dermatology|December 15, 2007
IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivinCaroline Hilmi, Lionel Larribere, Sandy Giuliano, et al.
Oncotarget|December 22, 2016
Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategiesMélanie Guyot, Caroline Hilmi, Damien Ambrosetti, et al.
Current Biology : CB|May 16, 2003
Reconstituted skin from murine embryonic stem cellsChristelle Coraux, Caroline Hilmi, Matthieu Rouleau, et al.
Genes & Development|September 6, 2005
The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosisLionel Larribere, Caroline Hilmi, Mehdi Khaled, et al.
Endocrine-Related Cancer|October 1, 2008
ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2Sunil Pancholi, Anne E Lykkesfeldt, Caroline Hilmi, et al.
Pest Management Science|March 15, 2025
Aminoisothiazolamides, a new class of potent inhibitors of lysyl-tRNA synthetaseDavid Bernier, David M Barber, Guido Bojack, et al.
Pageof 1